PAA 0.00% 17.0¢ pharmaust limited

Amylyx class action Relyvrio, page-11

  1. 12,175 Posts.
    lightbulb Created with Sketch. 6206
    No The FDA wont be gun shy they have no personal opinion its purely processed on OUR SCIENCE FDA do not compare Treatments , the Mechanism of Action for MPL utilising the mTOR Pathway is unique ,, we are stand alone ,, very close to First In Class Medicine ,,,

    I know of no other company that has been able to deliver a beneficial dose of medication through the Blood Brain Barrier utilising the mTOR Pathway ..

    I just had a conversation surrounding could MPL be utilised to carry a payload of other Medication with it through the Blood Brain Barrier..

    The Human Body is one of the most powerful Filters in Nature ,,, we are designed to screen out everything before it makes it across that Barrier ..


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
0.000(0.00%)
Mkt cap ! $82.69M
Open High Low Value Volume
17.0¢ 17.0¢ 16.3¢ $108.2K 647.7K

Buyers (Bids)

No. Vol. Price($)
2 109170 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 117939 4
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.